Health Security for Children: Inside the SPARK Accelerator with AcQumen Medical and Vesynta
Release Date: 11/23/2025
Health Security for Children: Inside the SPARK Accelerator with AcQumen Medical and Vesynta
BioTalk with Rich Bendis
This episode brings together three leaders working at the intersection of pediatric innovation, health security, and early-stage commercialization. Kolaleh Eskandanian, Program Director of SPARK, is joined by founders Dori Jones of AcQumen Medical and Jugal Suthar of Vesynta for a conversation about advancing breakthrough solutions for children. They discuss the mission behind the BARDA-funded SPARK for Innovations in Pediatrics Hub at Children's National Hospital, the challenges of developing technologies for pediatric populations, and the impact of public-private partnerships in moving...
info_outline
Crab Trap Winner Spotlight: Perfusion Medical's Mission Against Hemorrhagic Shock
BioTalk with Rich Bendis
In this episode of BioTalk, CEO Gerard Eldering explains how Perfusion Medical is addressing a problem that trauma physicians and military medics have been struggling with for decades: capillary compression. Perfusion Medical is developing a drug aimed at treating hemorrhagic shock and other ischemic conditions. PM‑208 is a novel IV therapeutic designed to restore capillary blood flow, resolve ischemia, and protect vital organs. The team has advanced this work with $19 million in Department of Defense funding. He describes the scale of the unmet need, why PM‑208 is both organ- and...
info_outline
Betting Big on Innovation in the Desert with BioHealth Las Vegas
BioTalk with Rich Bendis
In this episode of BioTalk, Rich Bendis sits down with Councilman Brian Knudsen, Jamie Schwartz of UNLV, and Vance Farrow from the Nevada Governor’s Office of Economic Development to spotlight the rapid emergence of Southern Nevada as a rising force in the biohealth landscape. The conversation covers the launch of the $10 million BioHealth Innovation Challenge, the Desert Forge Venture Fund, and the revitalization of BioTech Vegas, all designed to attract industry anchors, fuel early-stage startups, and cultivate a thriving innovation ecosystem. They also explore how strong collaboration...
info_outline
Maryland’s Economic Vision for BioHealth with Commerce Secretary Harry Coker, Jr.
BioTalk with Rich Bendis
In this episode of BioTalk with Rich Bendis, Harry Coker, Jr., Secretary of the Maryland Department of Commerce, joins the podcast to discuss Maryland’s rising momentum as a global biohealth and technology leader. Secretary Coker shares his unique journey from the CIA, NSA, and White House to leading Maryland’s economic development strategy, highlighting the state’s strengths in life sciences, its appeal to global investors, and the importance of public-private partnerships in accelerating innovation. Topics include Maryland’s recent recognition as a Top 3 biopharma hub, the...
info_outline
Building Maryland’s BioHealth Future: Maryland Commerce’s Stefanie Trop on Growing the Life Sciences Sector
BioTalk with Rich Bendis
Building Maryland’s BioHealth Future: Maryland Commerce’s Stefanie Trop on Growing the Life Sciences Sector In this episode of BioTalk with Rich Bendis, Stefanie Trop, Ph.D., Director of Life Sciences at the Maryland Department of Commerce joins the conversation to discuss Maryland’s position as a leading life sciences hub. Stefanie shares how the Department of Commerce supports company attraction and growth through programs like Global Gateway, and how it’s amplifying the state’s recent #3 biopharma hub ranking. The discussion also explores Maryland’s unique ecosystem, including...
info_outline
Inside FNIH: Dr. Stacey Adam on Smarter, Human-Based Research
BioTalk with Rich Bendis
In this episode of BioTalk, Rich Bendis welcomes Dr. Stacey Adam, Vice President of Science Partnerships, Translational Science at the Foundation for the National Institutes of Health (FNIH), to discuss how public-private partnerships are advancing scientific innovation. Dr. Adam introduces the mission of FNIH and its unique role in bridging government, industry, and academia to accelerate biomedical progress. She highlights the Validation and Qualification Network (VQN), a new initiative working to overcome barriers to the adoption of New Approach Methodologies (NAMs) and explains how...
info_outline
Reimagining Gene and Cell Therapy: Helen Sabzevari on Precigen’s Breakthroughs in Precision Medicine
BioTalk with Rich Bendis
In this episode of BioTalk, Rich Bendis welcomes Dr. Helen Sabzevari, President and CEO of Precigen, to discuss the company’s cutting-edge science in gene and cell therapy. Dr. Sabzevari shares how Precigen’s unique AdenoVerse® platform has powered the development of PRGN-2012, a potential first-in-class therapeutic currently under FDA priority review for the treatment of adults with recurrent respiratory papillomatosis (RRP), a rare and devastating disease. She also highlights advances across Precigen’s broader pipeline in immuno-oncology and autoimmune disease and...
info_outline
Decentralizing Discovery: Lara Mangravite and the Mission of Digitalis Commons
BioTalk with Rich Bendis
In this episode of BioTalk, Lara Mangravite, PhD, Executive Director of Digitalis Commons, joins the conversation to explore how scientific research is shifting in the U.S.—from centralized, institutional models to a more decentralized, innovation-driven landscape. She shares the mission of Digitalis Commons and explains how the organization is working at the intersection of technology, research, and public good to address systemic barriers in health and healthcare. Drawing from her recent article, "Notes on Catalyzing Health," Lara discusses the growing role of independent...
info_outline
Inside CTMC: Amy Hay on Reshaping Cell and Gene Therapy
BioTalk with Rich Bendis
In this episode of BioTalk, Amy C. Hay, Chief Business and Strategy Officer at the Cell Therapy Manufacturing Center (CTMC), joins the conversation to explore the evolving landscape of cell and gene therapy. Amy shares insights from her extensive career in oncology care and innovation, highlighting the role CTMC—a joint venture between National Resilience and MD Anderson Cancer Center—is playing in accelerating the transition from discovery to commercialization. She discusses the current state of the industry, what disruption really means in this context, and how new business models can...
info_outline
Decoding Federal Dollars: Grant Engine CEO Sam Tetlow on the Evolving Biohealth Funding Map
BioTalk with Rich Bendis
In this episode of BioTalk, Sam Tetlow, Founder and CEO of Grant Engine, joins the conversation to unpack how companies can successfully navigate the rapidly changing world of non-dilutive funding. With continued resolutions, shifting agency priorities, and evolving leadership at HHS and beyond, 2025 presents both new hurdles and new opportunities for biotech and health innovators. Sam shares actionable insights on what’s changed under the current administration, where funding gaps exist, and how early-stage companies can align proposals with both individual program officers and federal...
info_outlineThis episode brings together three leaders working at the intersection of pediatric innovation, health security, and early-stage commercialization. Kolaleh Eskandanian, Program Director of SPARK, is joined by founders Dori Jones of AcQumen Medical and Jugal Suthar of Vesynta for a conversation about advancing breakthrough solutions for children. They discuss the mission behind the BARDA-funded SPARK for Innovations in Pediatrics Hub at Children's National Hospital, the challenges of developing technologies for pediatric populations, and the impact of public-private partnerships in moving lifesaving tools to market. Dori and Jugal share what their companies are building, the inflection points that shaped their journeys, and how BioHealth Innovation’s Entrepreneur-in-Residence program supported their progress. The group reflects on lessons learned, the value of mentorship, and how collaborative accelerator ecosystems help drive breakthroughs in pediatric care, preparedness, and health equity.
Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).
Dr. Kolaleh Eskandanian is a nationally recognized leader in pediatric health innovation with more than twenty years of experience across academia, government, and industry. She previously served as Vice President and Chief Innovation Officer at Children’s National Hospital, where she founded Innovation Ventures and secured significant federal funding, patents, and licensed technologies. She now leads the BARDA-funded SPARK Accelerator Hub for Pediatrics and serves as Chief Strategy and Innovation Officer at Compremium AG, while also supporting early-stage innovators as an angel investor with Citrine Angels.
Dori Jones is the Co-Founder and CEO of AcQumen Medical, a medtech company developing UltraTrac, the first ultrasound-guided impedance technology designed for rapid assessment of hemodynamics in critically ill infants and children. She brings nearly two decades of experience across R&D, clinical education, and commercialization roles supporting cardiac and critical care devices at organizations ranging from early startups to Abbott and Medtronic. Her commitment to pediatric innovation is shaped in part by her experience as the mother of a NICU and PICU patient.
Dr. Jugal Suthar is the Co-Founder and CEO of Vesynta, a precision medicine company developing the DosoLogic platform, the first marketplace-enabled precision prescribing software aimed at improving accuracy and safety for every patient. His background includes clinical work as a hospital pharmacist and roles in drug development in the pharmaceutical industry. His PhD in precision medicine fuels his focus on bringing personalized dosing insights to populations often underrepresented in clinical research.